How many people live with a given rare disease? How many more remain undiagnosed? Can we develop a formula to predict improvement in diagnosis rates across diseases? A recent article by the International Society for Pharmacoeconomics and Outcomes Research attempts to answer these riddles.
The world of orphan drugs is evolving quickly.
We keep our feet on the ground, our sleeves rolled up, and our ears open.
Let us share what we’ve learned and apply our thinking to your challenges.